MYMohammad Javad Yazdanpanah

Mohammad Javad Yazdanpanah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammad Javad Yazdanpanah has a total of 176 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Identifying determinants of treatment failure with intralesional meglumine antimoniate in patients with cutaneous leishmaniasis

    by Elaheh Andakhshideh, Mohammad Javad Yazdanpanah, Bita Kiafar, Vahid Mashayekhi Goyonlo, Mona Najaf Najafi, Mobin Dorost


  • Open Access

    Is Acupuncture Effective in Diminishing Frown Lines? Evidence From a Randomized Controlled Trial

    by Hossein Haghir, Mohammad Javad Yazdanpanah, Seyed Kazem Farahmand, Majid Khadem‐Rezaiyan, Hoda Azizi

    Background: As life expectancy rises, facial rejuvenation has gained significance.Aims: This study aimed to evaluate the effects of body and facial acupuncture on reducing frown lines in women aged 30–59 in Mashhad, Iran.Patients/Methods: In this double‐arm randomized wait‐list controlled trial, 72 participants were randomly assigned to either an intervention group, receiving facial and body acupuncture twice weekly for 6 weeks, or a control group with no treatment. The primary outcome was assessed using the Global Aesthetic Improvement Scale (GAIS) based on standardized photographs. Secondary outcomes included the Subject Satisfaction Scale (SSS) and Quality of Life (QOL) scores. Measurements were taken at three time points: week 0 (pre‐treatment), week 7 (post‐treatment), and week 12 (follow‐up).Results: At week 7, 63% of the intervention group showed reduced frown lines at rest, and 72% during maximum frowning, significantly outperforming the control group. The improvements observed in the intervention group persisted at week 12 with 68.6% at rest and 57.2% at maximum frown. The SSS indicated that 72.2% and 62.9% of the intervention group were satisfied with their frown lines at weeks 7 and 12, respectively. Notable QOL improvements in social functioning were observed in the intervention group compared to the control group at both weeks 7 and 12. No serious adverse effects were reported; minor bleeding occurred in 4.86% of treatment sessions, resulting in bruising in 0.69%.Conclusion: This study demonstrates that facial and body acupuncture is an effective and safe method for reducing frown lines.Trial Registration: IRCT20230204057316N1 (https://irct.behdasht.gov.ir/trial/68408)


  • Open Access

    Effects of Face and Body Acupuncture on Glabellar Frown Lines in Women Aged 30-59: a Study Protocol for a Double-Arm Randomized Waitlist-Controlled Trial

    by Hossein Haghir, Mohammad Javad Yazdanpanah, Majid Khadem-Rezaiyan, Farshid Bidouei, Hoda Azizi

    Hossein Haghir, Mohammad Javad Yazdanpanah, Majid Khadem-Rezaiyan, Farshid Bidouei, Hoda Azizi. J Acupunct Meridian Stud 2024;17:221-8. https://doi.org/10.51507/j.jams.2024.17.6.221


  • Open Access

    The additional effect of 5% atorvastatin shampoo in the treatment of adult patients with mild to moderate seborrheic dermatitis of the scalp: A prospective, randomised, double-blind trial

    by Farhad Miri, Masoumeh Sadeghi, Mohammadreza Abbaspour, Sara Samadi, Mohammad Javad Yazdanpanah

    Background: Seborrheic dermatitis (SD) is a long-lasting inflammatory skin condition that predominantly impacts regions abundant in sebaceous glands, including the scalp. Objectives: To assess the efficacy and anti-inflammatory effect of atorvastatin as an additive treatment among SD patients. Methods: In a prospective, randomised, double-blind trial, 46 patients over 18 years old with mild to moderate scalp SD were randomly assigned to receive either 2% ketoconazole shampoo or 2% ketoconazole shampoo plus 5% atorvastatin. The severity of dermatitis was assessed based on the symptom scale of seborrheic dermatitis (SSSD), and the variables of erythema, scaling, and itching, at baseline and 4 weeks after the intervention. Results: Based on our analyses, both treatment methods significantly reduced the SSSD scores. However, the average SSSD score in patients using ketoconazole shampoo plus atorvastatin decreased by an average of five points after 1 month. This reduction was comparable to the average decline of 3.5 points observed in the group using ketoconazole shampoo alone. Specifically, the severity of dermatitis, as assessed by the SSSD score, significantly decreased by 1.92 points more, in individuals using the atorvastatin-containing shampoo compared to the comparison group (P = 0.02). Limitation: This research was conducted at a single centre which limits the validity of the findings. Conclusion: The results of this study suggest that shampoo containing atorvastatin provides a statistically significant effect compared to ketoconazole shampoo alone, indicating its potential as an alternative treatment for SD. The treatment notably alleviates symptoms associated with scaling and itching which are the common manifestations of the condition.

  • Open Access

    Localization of Lupoid Leishmaniasis on the face: A case control study

    by Mohammad J. Yazdanpanah, Rosita Moradpour, Ahmad R. Taheri, Habibollah Esmaily, Omalbanin Afroushteh

    Background: In Lupoid Leishmaniasis, erythematous to brown papules often occur around a central old scar, which can expand over time. For unclear reasons, these lesions tend to develop on the facial area.Objectives: This study was conducted to study the distribution of Lupoid Leishmaniasis lesions on the face and compare them with those of acute leishmaniasis.Methods: This case‐control study included 100 patients with the acute type of cutaneous leishmaniasis and Lupoid Leishmaniasis who were referred to the dermatology clinics of Ghaem and Emamreza hospitals. We recorded lesion morphology, demographic data and locations of lesions on the face.Results: We enrolled 55 patients with acute leishmaniasis and 45 patients with Lupoid Leishmaniasis, with a mean age of 21.30 ± 20.71 years. There were no significant differences in age (p = 0.78), gender (p = 0.48), and the distribution of lesions on different anatomical areas (p = 0.22) between the two groups. In both groups, the involvement of the zygoma was significantly higher than in other areas on the face (p = 0.001).Conclusions: Our study reveals that the anatomical location does not play a role in lesion evolving into Lupoid form.


  • The Effect of a Combined Topical Herbal Cream on the Incidence and Severity of Striae Gravidarum in Primiparous Women: A Randomized Clinical Trial

    by Somayeh Alirezaei, Mohammad Javad Yazdanpanah, Habibollah Esmaeili, Nayereh Khadem, Naghmeh Zabolinejad, Fatemeh Sadeghi, Robab Latifnejad Roudsari

    Background: Striae gravidarum, which occurs in most pregnancies, is unpleasant for women, and its treatment is costly. A preventive measure for this condition is applying herbal oils to maintain the skin's elasticity. The current study investigated the effect of a topical combined herbal cream on the occurrence and severity of striae gravidarum in primiparous women. Methods: In this triple-blind randomized clinical trial, 90 primiparous women in their first trimester of pregnancy, attending healthcare centres in Mashhad, Iran, were randomly allocated into two groups of herbal cream and placebo, from which 54 completed the study. The intervention group received 0.3 g of the cream, topically, composed of Calendula (Pot marigold), Anthemis nobilis (Chamomile), Pelargonium Graveolens (Rose Geranium), Theobroma oil (Cocoa Butter) and Soybean, twice a day for three days a week from 14-16 to 27-30 weeks of gestation and the placebo group received a moisturizing cream. At the gestational age of 38-40 weeks, the incidence and severity of striae on the abdominal skin were evaluated using the Atwal numerical scoring system and digital photography. Results: There was a significant difference between the prevalence of striae in the intervention and placebo group (43.3% vs 87.5%) (P<0.0001). Also, a significant difference was seen between the two groups in terms of the severity of the striae (P < 0.001). In the intervention group, the severity of striae in 86.7%, 13.3%, and 0% of the cases was mild, moderate, and severe, respectively, whereas, in the placebo group, it was occurred as mild, moderate, and severe in 37.5%, 58.3%, and 4.2% of the cases. Conclusion: Considering the effect of topically applied herbal cream, it is recommended that health care providers suggest pregnant women to use such herbal creams to avoid striae gravidarum development. Clinical Trial Registration Number: IRCT20190305042927


  • Open Access

    Higher Serum Vitamin D Levels have a Positive Association with the Incidence of Recidivans Form of Cutaneous Leishmaniasis; A Cross-Sectional Study

    by Mohammad Razmyar, Mohammad J. Yazdanpanah, Vahid Mashayekhi-Goyonlo, Mohammad Khajedaluee, Payam Sharifan, Maliheh Dadgarmoghaddam, Gordon Ferns, Majid Ghayour-Mobarhan

    Background: Several manifestations of cutaneous leishmaniasis are related to the host's immune system and the species of parasite. Objective: There have been some studies on the relationship between vitamin D statuses in infectious diseases including cutaneous leishmaniasis. However, the results of these studies have been inconsistent. Materials and Methods: In this cross-sectional study, 147 patients with leishmaniasis were recruited and divided into the following categories: acute cutaneous leishmaniasis (n = 51), chronic cutaneous leishmaniasis (more than 1 year) (n = 26), and leishmaniasis recidivans (the appearance of new papular lesions around a previous scar) (n = 20), and a group of participants without leishmaniasis (n = 50), as a control group. Serum 25-hydroxyvitamin D [25(OH) D] level was analyzed. Result: There were significant differences in serum 25(OH) D between the groups with acute or chronic leishmaniasis and those with recidivans leishmaniasis (P = 0.013 and P = 0.022, respectively). The median serum level of vitamin D in the acute group was 13.7 ng/mL, in the chronic group was 16.05 ng/mL, in the recidivans group was 21.75 ng/mL, and in the control group was 17.97 ng/mL. Conclusion: Higher serum concentrations of 25(OH) vitamin D levels being associated with leishmaniasis recidivans.


  • Open Access

    Dermatologic Manifestations in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

    by Reza Boostani, Pouran Layegh, Mohammad Javad Yazdanpanah, Elham Vosoughi, Azadeh Mohammadi, Noseibe Joneidi, Reyhaneh Bazargani, Delaram Sayadpour Zanjani, Saeed Ebrahimzadeh

    - The human T cell lymphotropic virus type-1 (HTLV-1) is associated with adult T cell leukemia/lymphoma (ATL) and other disorders, including a slowly progressive demyelinating paraparesis, known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Dermatologic manifestations are common in patients infected with HTLV-1 infection. In this study, we evaluated the dermatologic lesions associated with HAM/TSP patients in Mashhad, Iran. Dermatological findings of 37 patients with HAM/TSP were investigated and compared with those of an HTLV-1 negative control group. A cutaneous biopsy was performed as needed, and the results were statistically analyzed. Results of the present study showed that 34 cases with HAM/TSP (91.9%) and 24 cases in the control group (64.9%) had at least one skin lesion or history of skin lesion before (P=0.010). Xerosis was found in 22 persons (59.5%) in the case group and 4 persons in the control group (10.8%) (P=0.000). Only xerosis was significantly associated with HAM/TSP. Skin manifestations were quite frequent in patients with HAM/TSP. Xerosis was significantly associated with HAM/TSP


  • The effect of platelet‐rich plasma injection in the treatment of androgenetic alopecia

    by Mousa Bayat, Mohammad Javad Yazdanpanah, Daryoush Hamidi Alamdari, Mahnaz Banihashemi, Maryam Salehi

    Summary: Background: Androgenetic alopecia is the most common type of hair loss in men, which is manifested by a progressive terminal hair loss in specific areas of scalp. Platelet‐rich plasma (PRP) is among treatment options for androgenetic alopecia. PRP is a human platelet concentrate in a small volume of plasma containing certain cytokines.Aim: The aim of this study was to evaluate the efficacy and safety of autologous PRP in treatment of male androgenetic alopecia.Methods: This was a clinical trial in 19 patients with grade III vertex to grade V androgenetic alopecia referring to the Clinic of Ghaem Hospital between March 2015 and March 2016. All obtained liquid PRP (5 cc) was injected at around 125 points (equals to 125 cm2) into the scalp, and operation was repeated in three sessions at 0, 4, and 8 weeks. We took macroscopic and dermoscopic pictures of each patient in 0, 4, and 8 weeks and 3 months after the last injection session. A dermatologist evaluated the treatment response using dermoscopy photos.Result: Our results showed that the trend of hair thickness and number variations during study period was significant (P < 0.001). However, there was no significant change in the hair thickness from the second injection forward. Our findings indicate the number of hair follicles during follow‐up in pairwise comparison was significantly more than baseline.Conclusion: Findings of our study were in line with other studies in this field and showed that the use of PRP as a new and safe treatment can be effective in androgenetic alopecia.


  • Real life management of chronic urticaria: Multicenter and cross sectional study on patients and dermatologists in Iran

    by Alireza Firooz, AliAsghar Akhlaghi, Pejman Golbidi, Marzieh Pourjafari, Fahimeh Abdollahimajd, Hamideh Azimi, Mahnaz Banihashemi, Farshid Darvish Damavandi, Abdol Reza Erfani, Saeedeh Farajzadeh, et al.

    Recently, advances in understanding the etiology of urticaria and updates of diagnostic and therapeutic management guidelines have drawn attention to chronic urticaria (CU) morbidity. This study aimed to evaluate Iranian dermatologists' practice and real life management of CU patients. A total of 35 dermatologists and 443 patients were included in the study. Number of female patients was 321 (72.5%). Mean (Standard Deviation) age of the study patients was 38 (13) years and the median (Inter Quartile Range) of disease duration was 12 (6‐ 48) months. Severity of patients' symptoms was mild for 32.1%, moderate for 38.7%, severe for18.8% and 10.4% of them had no evident signs or symptoms. The most common diagnostic methods were physical examination (96.6%), differential blood count (83.5%), erythrocyte sedimentation rate (77.4%), and C‐reactive protein (62.8%). The number of dermatologists prescribed non‐sedating antihistamines (nsAH) in regular dose and high dose mono therapy were 26 (74%) and 6 (17%), respectively. About 66% of dermatologists were familiar with British Association of Dermatologists (BAD) guideline. The most common first‐line treatment for CU by Iranian dermatologists was non‐sedating antihistamines in regular or high doses. The real‐life management of patients with CU in Iran was in accordance with the available practice guidelines.